Cost-Effectiveness Analysis of Pharmacokinetic-Guided Prophylaxis Versus Standard Prophylaxis in Adults with Severe Hemophilia A in China

被引：0
作者：
Huang, Kun [1 ]
机构：
[1] Zhejiang Univ, Affiliated Hosp 1, Dept Pediat, Sch Med, 1367 Wenyi West Rd, Hangzhou 311121, Zhejiang, Peoples R China
来源：
ADVANCES IN THERAPY | 2024年 / 41卷 / 04期
关键词：
Hemophilia A; Pharmacokinetics; Cost-effectiveness; Prophylaxis; Bleeding;
D O I：
10.1007/s12325-024-02786-0
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：1759 / 1761
页数：3
相关论文
共 50 条
[1]   Letter to the Editor Regarding “Cost-Effectiveness Analysis of Pharmacokinetic-Guided Prophylaxis Versus Standard Prophylaxis in Adults with Severe Hemophilia A in China” [J].
Kun Huang .
Advances in Therapy, 2024, 41 :1759-1761
[2]   Cost-Effectiveness Analysis of Pharmacokinetic-Guided Prophylaxis Versus Standard Prophylaxis in Adults with Severe Hemophilia A in China [J].
Gu, Congling ;
Huang, Hui ;
Han, Yi .
ADVANCES IN THERAPY, 2022, 39 (08) :3777-3788
[3]   Cost-Effectiveness Analysis of Pharmacokinetic-Guided Prophylaxis Versus Standard Prophylaxis in Adults with Severe Hemophilia A in China [J].
Congling Gu ;
Hui Huang ;
Yi Han .
Advances in Therapy, 2022, 39 :3777-3788
[4]   A Response to: Letter to the Editor Regarding "Cost-Effectiveness Analysis of Pharmacokinetic-Guided Prophylaxis Versus Standard Prophylaxis in Adults with Severe Hemophilia A in China" [J].
Gu, Congling ;
Han, Yi .
ADVANCES IN THERAPY, 2024, 41 (04) :1762-1764
[5]   A Response to: Letter to the Editor Regarding “Cost-Effectiveness Analysis of Pharmacokinetic-Guided Prophylaxis Versus Standard Prophylaxis in Adults with Severe Hemophilia A in China” [J].
Congling Gu ;
Yi Han .
Advances in Therapy, 2024, 41 :1762-1764
[6]   Pharmacokinetic-guided versus standard prophylaxis in hemophilia: a systematic review and meta-analysis [J].
Kraemmer, Daniel ;
Koenigsbruegge, Oliver ;
Moik, Florian ;
Wildner, Brigitte ;
Ay, Cihan ;
Pabinger, Ingrid .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2023, 21 (12) :3432-3449
[7]   Cost-effectiveness Analysis of Prophylaxis Versus On-demand Treatment for Children With Moderate or Severe Hemophilia A in China [J].
Zhou, Yaohan ;
Li, Zhengping ;
Liu, Guoqing ;
Chen, Zhenping ;
Yao, Wanru ;
Li, Gang ;
Zhen, Yingzi ;
Cheng, Xiaoling ;
Ai, Di ;
Huang, Kun ;
Cao, Wang ;
Wu, Runhui .
CLINICAL THERAPEUTICS, 2024, 46 (12) :1010-1015
[8]   Cost-effectiveness analysis of pharmacokinetic-driven prophylaxis vs. standard prophylaxis in patients with severe haemophilia A [J].
Iannazzo, Sergio ;
Cortesi, Paolo A. ;
Crea, Roberto ;
Steinitz, Katharina ;
Mantovani, Lorenzo G. ;
Gringeri, Alessandro .
BLOOD COAGULATION & FIBRINOLYSIS, 2017, 28 (06) :425-430
[9]   Cost-effectiveness Analysis of Prophylaxis Versus On-demand Treatment for Children With Hemophilia B Without Inhibitors in China [J].
Liu, Guoqing ;
Xin, Qing ;
Chen, Zhenping ;
Li, Lanting ;
Chen, Ting ;
Wu, Runhui .
CLINICAL THERAPEUTICS, 2021, 43 (09) :1536-1546
[10]   Pharmacokinetic-guided prophylaxis improved clinical outcomes in paediatric patients with severe haemophilia A [J].
Huang, Kun ;
Zhen, Yingzi ;
Li, Gang ;
Wu, Xinyi ;
Chen, Zhenping ;
Wu, Runhui .
HAEMOPHILIA, 2021, 27 (04) :E450-E457
12345